Bibliografía del Parkinson
La información sobre la enfermedad de Parkinson que in-pacient.es pone a tu disposición está basada en las fuentes bibliográficas que se citan a continuación, así como en la propia experiencia del Comité Editorial y revisores de in-pacient.es Además ésta se revisa de forma periódica por dicho Comité Editorial, con el fin de mantenerla actualizada.
Los enlaces dirigidos a páginas web pueden no estar disponibles por causas ajenas a nuestra voluntad, por lo que pedimos disculpas y agradeceremos que nos informes de estas anomalías para poder subsanarlas a través del siguiente formulario
Referencias:
Alonso Cánovas A et al.
Agonistas dopaminérgicos en la enfermedad de Parkinson
Neurología 2011;
Bayés-Rusiñol A et al.
Consciencia de disfagia en la enfermedad de Parkinson
Rev Neurol. 2011 Dec 1;53(11):664-72.
Bega D et al.
Recognition and Treatment of Depressive Symptoms in Parkinson’s Disease: The NPF Dataset.
J Parkinsons Dis. 2014 Jul 17. [Epub ahead of print]
Buttery PC et al.
Treating Parkinson’s disease in the 21st century: can stem cell transplantation compete?
J Comp Neurol. 2014 Aug 15;522(12):2802-16
Chacón JR
Concepto de enfermedad de Parkinson. Enfermedad multisistémica: ¿todos los núcleos son iguales?
Rev Neurol 2010; 50 (Supl 4): S2-S3
Elbers RG et al.
Self-report fatigue questionnaires in multiple sclerosis, Parkinson’s disease and stroke: a systematic review of measurement properties.
Qual Life Res. 2012 Aug;21(6):925-44
Friedlander AH et al.
Parkinson disease: systemic and orofacial manifestations, medical and dental management.
J Am Dent Assoc. 2009 Jun;140(6):658-69.
Gao X et al.
Prospective study of dietary pattern and risk of Parkinson disease.
Am J Clin Nutr. 2007 Nov;86(5):1486-94.
García-Ramos R et al.
Informe de la Fundación del Cerebro sobre el Impacto Social de la Enfermedad de Parkinson en España(2 de julio de 2013).
Acceso en: http://www.sen.es/component/attachments/download/175 [Fecha de consulta Feb. 2015]
Gazewood JD et al.
Parkinson disease: an update.
Am Fam Physician. 2013 Feb 15;87(4):267-73.
Gómez-Soriano J et al.
Valoración y cuantificación de la espasticidad: revisión de los métodos clínicos, biomecánicos y neurofisiológicos
Rev Neurol. 2012 Aug 16;55(4):217-26.
Grimes D et al.
Canadian Guidelines on Parkinson’s Disease
Can J Neurol Sci. 2012;39: Suppl 4: S1-S30
Grupo de trabajo de la Guía de Práctica Clínica para el Manejo de Pacientes con Enfermedad de Parkinson. Guía de Práctica Clínica para el Manejo de Pacientes con Enfermedad de Parkinson. Ministerio de Sanidad, Servicios Sociales e Igualdad. Instituto Aragonés de Ciencias de la Salud; 2014. Guías de Práctica Clínica en el SNS. http://www.guiasalud.es/GPC/GPC_546_Parkinson_IACS_compl.pdf [fecha de consulta Junio 2017]
Haralur SB
Clinical strategies for complete denture rehabilitation in a patient with Parkinson disease and reduced neuromuscular control.
Case Rep Dent. 2015;2015:352878.
Harris Ricardo J et al.
Pathophysiology and oral manifestations of Parkinson´s disease: A review update
Av Odontoestomatol 2013;29(3):151-157
Hauser RA
Early pharmacologic treatment in Parkinson’s disease.
Am J Manag Care. 2010 Mar;16 Suppl Implications:S100-7.
Kaur T et al.
Parkinson’s disease and periodontitis – the missing link? A review.
Gerodontology. 2015 Feb 9. doi: 10.1111/ger.12188. [Epub ahead of print]
Litvan I et al.
Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines.
Mov Disord. 2012 Mar;27(3):349-56.
Maass A et al.
Sleep and non-motor symptoms in Parkinson’s disease
J Neural Transm. 2013 Apr;120(4):565-9.
Madan A et al.
Management of Lower Urinary Tract Symptoms in Parkinson’s Disease in the Neurology Clinic.
Int J Neurosci. 2017 May 25:1-14.
Marinus J et al.
Health related quality of life in Parkinson’s disease: a systematic review of disease specific instruments
J Neurol Neurosurg Psychiatry. 2002 Feb;72(2):241-8.
Martínez-Sánchez F
Trastornos del habla y la voz en la enfermedad de Parkinson
Rev Neruol 2010: 51(9):542-50
Murman DL
Early treatment of Parkinson’s disease: opportunities for managed care.
Am J Manag Care. 2012 Sep;18(7 Suppl):S183-8.
NICE ( National Institute for Health and Clinical Excellence)
NICE clinical guideline 35 Parkinson’s disease: diagnosis and management in primary and secondary care
http://www.nice.org.uk/nicemedia/live/10984/30088/30088.pdf [Fecha consulta Marzo 2014]
Opara JA et al.
Quality of life in Parkinson’s disease.
J Med Life. 2012 Dec 15;5(4):375-81
Ossig C et al.
Treatment of Parkinson’s disease in the advanced stage.
J Neural Transm. 2013 Apr;120(4):523-9
Pagonabarraga J et al.
[Dopaminergic treatment in Parkinson’s disease: what has each therapeutic family got to offer?].
Rev Neurol 2014; 58(1): 25-34.
Pahwav R et al.
Early diagnosis of Parkinson’s disease: recommendations from diagnostic clinical guidelines.
Am J Manag Care. 2010 Mar;16 Suppl Implications:S94-9.
Paré S et al.
Effect of daytime protein restriction on nutrient intakes of free-living Parkinson’s disease patients.
Am J Clin Nutr. 1992 Mar;55(3):701-7.
Park A et al.
Effects of a formal exercise program on Parkinson’s disease: A pilot study using a delayed start design
Parkinsonism and Related Disorders 20 (2014) 106e111
Powers KM et al.
Dietary fats, cholesterol and iron as risk factors for Parkinson’s disease.
Parkinsonism Relat Disord. 2009 Jan;15(1):47-52
Puy-Núñez A et al.
Tratamiento inicial de la enfermedad de Parkinson clínicamente establecida
Rev Neurol 2012; 54 (Supl 5): S9-14
Ribaric S.
The pharmacological properties and therapeutic use of apomorphine.
Molecules. 2012 May 7;17(5):5289-309.
Schrag A et al.
Depression rating scales in Parkinson’s disease: critique and recommendations.
Mov Disord. 2007 Jun 15;22(8):1077-92.
Singer C
Managing the patient with newly diagnosed Parkinson disease.
Cleve Clin J Med. 2012 Jul;79 Suppl 2:S3-7
Thacker EL et al.
Recreational physical activity and risk of Parkinson’s disease.
Mov Disord. 2008 Jan;23(1):69-74.
Tomlinson CL et al.
Physiotherapy intervention in Parkinson’s disease: systematic review and meta-analysis.
BMJ. 2012 Aug 6;345:e5004.
Uc EY et al.
Phase I/II randomized trial of aerobic exercise in Parkinson disease in a community setting.
Neurology. 2014 Jul 29;83(5):413-25
Yu QJ et al. Parkinson disease with constipation: clinical features and relevant factors. Sci Rep. 2018 Jan 12;8(1):567
Xu q et al.
Physical activities and future risk of Parkinson disease.
Neurology. 2010 Jul 27;75(4):341-8